Indicators
Indicators
Value
Direction
MACD(12,26,9)
2.112
Neutral
RSI(14)
50.312
Neutral
STOCH(KDJ)(9,3,3)
68.628
Neutral
ATR(14)
11.439
High Vlolatility
CCI(14)
129.835
Buy
Williams %R
25.799
Buy
TRIX(12,20)
-0.437
Sell
StochRSI(14)
100.000
Buy
Danaher Corp
DHRView Detailed Chart
196.310USD
+4.265+2.22%
Close 04/23, 16:00（ET）Quotes delayed by 15 min
140.48BMarket Cap
36.03P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.22%
5 Days
+2.96%
1 Month
-7.12%
6 Months
-23.32%
Year to Date
-14.48%
1 Year
-22.44%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
28
analysts
BUY
Current Rating
246.384
Target Price
28.28%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Danaher Corp
DHR
28
Boston Scientific Corp
BSX
34
Intuitive Surgical Inc
ISRG
33
Thermo Fisher Scientific Inc
TMO
33
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
32
1
2
3
...
18
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Neutral
Moving Average
Indicators
Value
Direction
MA5
190.166
Buy
MA10
189.498
Buy
MA20
193.341
Buy
MA50
202.296
Sell
MA100
217.338
Sell
MA200
239.182
Sell
News
More news coming soon, stay tuned...
Company
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company codeDHR
CompanyDanaher Corp
CEOMr. Rainer M. Blair
Websitehttps://www.danaher.com/
